BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wormwood KL, Aslebagh R, Channaveerappa D, Dupree EJ, Borland MM, Ryan JP, Darie CC, Woods AG. Salivary proteomics and biomarkers in neurology and psychiatry. Proteomics Clin Appl 2015;9:899-906. [PMID: 25631118 DOI: 10.1002/prca.201400153] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Galiana‐simal A, Muñoz‐martinez V, Calero‐bueno P, Vela‐romero M, Beato‐fernandez L. Towards a future molecular diagnosis of autism: Recent advances in biomarkers research from saliva samples. Int j dev neurosci 2018;67:1-5. [DOI: 10.1016/j.ijdevneu.2018.03.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.8] [Reference Citation Analysis]
2 Castagnola M, Scarano E, Passali GC, Messana I, Cabras T, Iavarone F, Di Cintio G, Fiorita A, De Corso E, Paludetti G. Salivary biomarkers and proteomics: future diagnostic and clinical utilities. Acta Otorhinolaryngol Ital 2017;37:94-101. [PMID: 28516971 DOI: 10.14639/0392-100X-1598] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 7.3] [Reference Citation Analysis]
3 Krief G, Haviv Y, Deutsch O, Keshet N, Almoznino G, Zacks B, Palmon A, Aframian DJ. Proteomic profiling of whole-saliva reveals correlation between Burning Mouth Syndrome and the neurotrophin signaling pathway. Sci Rep 2019;9:4794. [PMID: 30886243 DOI: 10.1038/s41598-019-41297-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
4 Hassaneen M, Maron JL. Salivary Diagnostics in Pediatrics: Applicability, Translatability, and Limitations. Front Public Health 2017;5:83. [PMID: 28473973 DOI: 10.3389/fpubh.2017.00083] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 4.2] [Reference Citation Analysis]
5 Giusti L, Ciregia F, Mazzoni MR, Lucacchini A. Proteomics insight into psychiatric disorders: an update on biological fluid biomarkers. Expert Review of Proteomics 2016;13:941-50. [DOI: 10.1080/14789450.2016.1230499] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
6 Bekes K, Mitulović G, Meißner N, Resch U, Gruber R. Saliva proteomic patterns in patients with molar incisor hypomineralization. Sci Rep 2020;10:7560. [PMID: 32371984 DOI: 10.1038/s41598-020-64614-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
7 Schubert KO, Stacey D, Arentz G, Clark SR, Air T, Hoffmann P, Baune BT. Targeted proteomic analysis of cognitive dysfunction in remitted major depressive disorder: Opportunities of multi-omics approaches towards predictive, preventive, and personalized psychiatry. J Proteomics 2018;188:63-70. [PMID: 29474866 DOI: 10.1016/j.jprot.2018.02.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
8 Neagu AN. Proteome Imaging: From Classic to Modern Mass Spectrometry-Based Molecular Histology. Adv Exp Med Biol 2019;1140:55-98. [PMID: 31347042 DOI: 10.1007/978-3-030-15950-4_4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
9 Tvarijonaviciute A, Zamora C, Ceron JJ, Bravo-Cantero AF, Pardo-Marin L, Valverde S, Lopez-Jornet P. Salivary biomarkers in Alzheimer's disease. Clin Oral Investig 2020;24:3437-44. [PMID: 31989369 DOI: 10.1007/s00784-020-03214-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
10 Ratajczak HV, Sothern RB. Measurement in saliva from neurotypical adults of biomarkers pertinent to autism spectrum disorders. Future Sci OA 2015;1:FSO70. [PMID: 28031921 DOI: 10.4155/fso.15.70] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
11 Katsani KR, Sakellari D. Saliva proteomics updates in biomedicine. J Biol Res (Thessalon) 2019;26:17. [PMID: 31890650 DOI: 10.1186/s40709-019-0109-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
12 Katsipis G, Tzekaki EE, Tsolaki M, Pantazaki AA. Salivary GFAP as a potential biomarker for diagnosis of mild cognitive impairment and Alzheimer's disease and its correlation with neuroinflammation and apoptosis. J Neuroimmunol 2021;361:577744. [PMID: 34655990 DOI: 10.1016/j.jneuroim.2021.577744] [Reference Citation Analysis]
13 Reale M, Gonzales-Portillo I, Borlongan CV. Saliva, an easily accessible fluid as diagnostic tool and potent stem cell source for Alzheimer's Disease: Present and future applications. Brain Res 2020;1727:146535. [PMID: 31669827 DOI: 10.1016/j.brainres.2019.146535] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 3.3] [Reference Citation Analysis]
14 Bhattarai KR, Kim HR, Chae HJ. Compliance with Saliva Collection Protocol in Healthy Volunteers: Strategies for Managing Risk and Errors. Int J Med Sci 2018;15:823-31. [PMID: 30008593 DOI: 10.7150/ijms.25146] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 10.8] [Reference Citation Analysis]
15 Manconi B, Liori B, Cabras T, Vincenzoni F, Iavarone F, Lorefice L, Cocco E, Castagnola M, Messana I, Olianas A. Top-down proteomic profiling of human saliva in multiple sclerosis patients. J Proteomics 2018;187:212-22. [PMID: 30086402 DOI: 10.1016/j.jprot.2018.07.019] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
16 Agresta AM, De Palma A, Bardoni A, Salvini R, Iadarola P, Mauri PL. Proteomics as an innovative tool to investigate frontotemporal disorders. Prot Clin Appl 2016;10:457-69. [DOI: 10.1002/prca.201500090] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
17 Iadarola P, Fumagalli M, Bardoni AM, Salvini R, Viglio S. Recent applications of CE- and HPLC-MS in the analysis of human fluids. Electrophoresis 2016;37:212-30. [PMID: 26426542 DOI: 10.1002/elps.201500272] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]